Antitumor effects of ribavirin in combination with TMZ and IFN-β in malignant glioma cells

The prognosis of gioblastoma, the standard chemotherapy agent for which is temozolomide (TMZ), remains poor despite recent advances in multimodal treatments. Therefore, it is necessary to identify and develop novel therapeutics for this malignant disease. Ribavirin, an anti-viral agent which is one...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncol Lett
Huvudupphovsmän: Ochiai, Yushi, Sumi, Koichiro, Sano, Emiko, Yoshimura, Sodai, Yamamuro, Shun, Ogino, Akiyoshi, Ueda, Takuya, Suzuki, Yutaka, Nakayama, Tomohiro, Hara, Hiroyuki, Katayama, Yoichi, Yoshino, Atsuo
Materialtyp: Artigo
Språk:Inglês
Publicerad: D.A. Spandidos 2020
Ämnen:
Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7475644/
https://ncbi.nlm.nih.gov/pubmed/32934745
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.12039
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk